3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
11
Burkitt Lymphoma
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Smoldering Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Neoplasms
1
Neoplasm Metastasis
1
Leukemia, Plasma Cell
1
Leukemia, Biphenotypic, Acute
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
Rituximab
4
Specimen Handling
3
Biopsy
3
ibrutinib
2
Cladribine
2
venetoclax
1
tovorafenib
1
polatuzumab vedotin
1
pembrolizumab
1
obinutuzumab
1
immunotoxin HA22
1
acalabrutinib
1
Vemurafenib
1
Spinal Puncture
1
Prednisone
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
High-Energy Shock Waves
1
Famotidine
1
Doxorubicin
1
Diphenhydramine
1
Dexamethasone
1
Cyclophosphamide
1
Calcium Dobesilate
1
CT-P10
1
Aspirin
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
dexamethasone acetate
×
30 days
×
Clear all
No trials found.